NO modulates myocardial O2 consumption in the nonhuman primate: An additional mechanism of action of amlodipine

American Journal of Physiology

Volumn 276, Issue 6 PART 2, 1999, Pages

  Forfia, Paul R ^a   Zhang, Xiaoping ^a   Knight, Delvin R ^b   Smith, Andrew H ^b   Doe, Christopher P A ^a   Wolfgang, Eric A ^b   Flynn, David M ^b   Wolin, Michael S ^a   Hintze, Thomas H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746513208     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342:821-828,1993.
2. Balligand, J.-L., L. Kobzik, X. Han, D. M. Kaye, L. Belhassen, D. S. O'Hara, R. A. Kelly, T. W. Smith, and T. Michel. Nitric oxide-dependent parasympathetic signalling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J. Biol. Chem. 270:14582-14586, 1995.
3. Bernstein, R. D., F. Y. Ochoa, X. Xu, P. R. Forfla, W. Q. Shen, C. I. Thompson, and T. H. Hintze. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ. Res. 79: 840-848,1996.
4. Borutaite, V., and G. C. Brown. Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide. Biochem. J. 315:295-299,1996.
5. Brown, G. C. Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem. J. 284:1-13,1992.
6. Brown, G. C., and C. E. Cooper. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEES Lett. 356: 295-298,1994.
7. Brudwig, G. W., T. H. Stevens, and S. I. Chan. Reactions of nitric oxide with cytochrome c oxidase. Biochemistry 19: 5275-5285,1980.
8. Bleeter, M. W. J., J. M. Cooper, V. M. Darley-Usmar, S. Moncada, and A. V. H. Schapira. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEES Lett. 345: 50-54,1994.
9. CONSENSUS Trial Group. Effects of enalipril on mortality in severe congestive heart failure. N. Engl. J. Med. 316:1429-1435, 1987.
10. Drapier, J.-C., and J. B. Hibbs. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. J. Clin. Invest. 78: 790-797,1986.
11. Elkayam, U., J. Amin, A. Mehra, J. Vasquez, L. Weber, and S. H. Rahimtoola. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 82:1954-1961,1990.
12. Gerritsen, M. E., and M. P. Printz. Sites of prostaglandin synthesis in the bovine heart and isolated bovine coronary microvessels. Circ. Res. 49:1152-1163,1981.
13. Granger, D. L., and A. L. Lehninger. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J. CellBiol. 95:527-535,1982.
14. Granger, D. L., R. R. Taintor, J. L. Cook, and J. B. Hibbs, Jr. Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J. Clin. Invest. 65: 357-370,1980.
15. Hibbs, J. B., Jr., R. R. Taintor, Z. Vavrin, and E. M. Rachlin. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157: 87-94,1988.
16. Hibbs, J. B., Jr., Z. Vavrin, and R. R. Taintor. L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138:550-565,1987.
17. Ignarro, L. J., H. Lippton, J. C. Edwards, W. H. Baricos, A. L. Hyman, P. J. Kadowitz, and C. A. Gruetter. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218: 739-749,1981.
18. Jones, D. P. Intracellular diffusion gradients of O and ATP. Am. J. Physiol. 250 (CellPhysiol. 19): C663-C675,1986.
19. Knowles, R. G., and S. Moncada. Nitric oxide as a signal in blood vessels. Trends Biochem. Sci. 17:399-402,1992.
20. Lancaster, J. R., and J. B. Hibbs, Jr. EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc. Natl. Acad. Sci. USA 87:1223-1227,1990.
21. Linz, W., G. Wiemer, P. Gohlke, T. Unger, and B. A. Scholkens. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev. 47:25-49,1995.
22. Malinski, T., F. Bailey, O. G. Zhang, and M. Chopp. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 13:355-358,1993.
23. Malmstrom, B. G., and R. Aasa. The nature of the CUA center in cytochrome oxidase. FEBS Lett. 325:49-52,1993.
24. Mombouli, J.-V., and P. M. Vanhoutte. Kinins and endothelial control of vascular smooth muscle. Annu. Rev. Pharmacol. Taxicol. 35:679-705,1995.
25. Mombouli, J.-V., S. Iliano, T. Nagao, T. Scott-Burden, and P. M. Vanhoutte. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ. Res. 71: 137-144, 1992.
26. Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem of mortality and reinfarction after myocardial infarction. M Engl. J. Med. 319:385-392,1988.
27. Packer, M., P. D. Kessler, and W. H. Lee. Calcium-channel blockade in the management of severe chronic heart failure: a bridge too far. Circulation 75, Suppl. V: V56-V64,1987.
28. Packer, M., W. H. Lee, N. Medina, M. Yushak, J. L. Bernstein, and P. D. Kessler. Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left-ventricular dysfunction. J. Am. Coll. Cardiol. 10:1301-1311, 1987.
29. Packer, M., C. M. O'Connor, J. K. Ghali, M. L. Pressler, P. E. Carson, R. N. Belkin, A. B. Miller, G. W. Neuberg, D. Frid, J. H. Wertheimer, A. B. Cropp, and D. L. DeMets. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N. Engl. J. Med. 335:1107-1114,1996.
30. Rakusan, K., M. F. Flanagan, T. Geva, J. Southern, and R. Van Praagh. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 86:38-46,1992.
31. Robertson, R. M., and D. Robertson. Drugs used for the treatment of myocardial ischemia. In: Goodman and Oilman's The Pharmacologie Basis of Therapeutics. New York: McGrawHill, 1996, chapt. 32, p. 767-774.
32. Saraste, M., and J. Castresana. Cytochrome oxidase evolved by tinkering with denitrification enzymes. FEES Lett. 341: 1-4, 1994.
33. Scott, R. A., W. G. Zumft, C. L. Coyle, and D. M. Dooley. Pseudomonas stutzeri N2U reductase contains CuA-type sites. Proc. Natl. Acad. Sci. USA 86:4082-4086,1989.
34. Sharpe, D. N., J. Murphy, R. Coxan, and S. F. Hannan. Enalapril in patients with chronic heart failure: a placebo controlled, randomized, double-blind study. Circulation 70: 271, 1984.
35. Shen, W. Q., T. H. Hintze, and M. S. Wolin. Nitric oxide: an important signalling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 92:3505-3512,1995.
36. Simonson, S. G., K. Welty-Wolf, Y. C. T. Huang, J. A. Griebel, M. S. Caplan, P. J. Fracica, and C. A. Piantadosi. Altered mitochondrial redox responses in gram negative septic shock in primates. Circ. Shock 43:34-43,1994.
37. SOLVD Investigators. Effect of enalipril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med. 325:293-302,1991.
38. Stadler, J., T. R. Billiar, R. D. Curran, D. J. Stuehr, J. B. Ochoa, and R. L. Simmons. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am. J. Physiol. 260 (Cell Physiol. 29): C910-C916,1991.
39. Stroker, M. E., A, M. Gerdes, and J. F. May. Regional differences in capillary density and myocyte size in the normal human heart. Anat. Rec. 202:187-191,1982.
40. Stuehr, D. J., and M. A. Marietta. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82: 7738-7742,1985.
41. Stuehr, D. J., and C. F. Nathan. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543-1555,1989.
42. Takehara, Y., H. Nakahara, Y. Inai, M. Yabuki, K. Hamazaki, T. Yoshioka, M. Inoue, A. A. Horton, and K. Utsumi. Oxygendependent reversible inhibition of mitochondrial respiration by nitric oxide. Cell Struct. Funct. 21:251-258,1996.
43. Umbreit, W. W., R. H. Burris, and J. F. Stauffer. The Solubility of Oxygen. Manometric Techniques (4th ed.). Minneapolis, MN: Burgess, 1964, p. 5-6.
44. Vanhoutte, P. M., C. M. Boulanger, and J. V. Mombouli. Endothelium-derived relaxing factors and converting enzyme inhibition. Am. J. Cardiol. 76:3E-12E, 1995.
45. Xie, Y. W., W. Q. Shen, G. Zhao, X. Xu, M. S. Wolin, and T. H. Hintze. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ. Res. 79: 381-387,1996.
46. Zhang, X., and T. H. Hintze. Amlodipine releases nitric oxide from canine coronary microvessels: a unique mechanism of action of a calcium channel-blocking agent. Circulation 97: 576-580,1998.
47. Zhang, X., Y. W. Xie, A, Nasjletti, X. Xu, M. S. Wolin, and T. H. Hintze. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 95: 176-182,1997.
48. Zile, M. R., R. Tanaka, J. R. Lindroth, F. G. Spinale, B. A. Carabello, and I. Mirsky. Left ventricular volume determined echocardiographiaclly by using a constant left ventricular epicardial long-axis/short-axis dimension ratio throughout the cardiac cycle. J. Am. Coll. Cardiol. 20:986-993,1992.